Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Jun-24 7:52 PM View:  | Amicus Therapeutics, Inc. (FOLD) | 06-Jun-24 | Grant | 11,847 | -- | -- | 27% 44.01K to 55.86K | |
| 15-Feb-24 5:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Feb-24 | Private Sale (Planned) | 1,114 | $132.96 | $148,122.00 | (4%) 24.83K to 23.72K | |
| 08-Feb-24 7:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-24 | Sale (Planned) | 980 | $134.21 | $131,522.00 | (4%) 23.7K to 22.72K | |
| 08-Feb-24 7:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-24 | Private Sale (Planned) | 1,121 | $142.24 | $159,446.00 | (5%) 22.96K to 21.84K | |
| 02-Feb-24 7:29 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-24 | Private Sale (Planned) | 1,457 | $140.79 | $205,132.00 | (7%) 22.29K to 20.83K | |
| 27-Dec-23 4:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 22-Dec-23 | Private Sale (Planned) | 10,000 | $126.75 | $1,267,450.00 | (34%) 29.52K to 19.52K | |
| 14-Dec-23 5:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Dec-23 | Option Exercise | 13,925 | $81.05 | $1,128,620.00 | 47% 29.52K to 43.45K | (6%) |
| 14-Dec-23 5:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Dec-23 | Planned Private Option Sale | 13,925 | $120.30 | $1,675,240.00 | (32%) 43.45K to 29.52K | |
| 11-Dec-23 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Dec-23 | Option Exercise | 300 | $81.05 | $24,315.00 | 1% 29.52K to 29.82K | |
| 11-Dec-23 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Dec-23 | Planned Option Sale | 300 | $120.10 | $36,031.00 | (1%) 29.82K to 29.52K | |
| 11-Dec-23 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Dec-23 | Option Exercise | 77,379 | $78.52 | $6,076,120.00 | 262% 29.52K to 106.9K | (3%) |
| 11-Dec-23 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Dec-23 | Planned Private Option Sale | 77,379 | $120.37 | $9,314,320.00 | (72%) 106.9K to 29.52K | |
| 08-Dec-23 7:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Dec-23 | Option Exercise | 8,396 | $77.81 | $653,293.00 | 28% 29.52K to 37.92K | (2%) |
| 08-Dec-23 7:09 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Dec-23 | Planned Private Option Sale | 8,396 | $120.03 | $1,007,780.00 | (22%) 37.92K to 29.52K | |
| 23-Aug-23 8:20 PM View: | Neurocrine Biosciences Inc. (NBIX) | 21-Aug-23 | Private Sale (Planned) | 3,198 | $107.38 | $343,388.00 | (10%) 32.72K to 29.52K | |
| 12-Jun-23 5:38 PM View: | Amicus Therapeutics, Inc. (FOLD) | 08-Jun-23 | Grant | 8,584 | -- | -- | 24% 35.43K to 44.01K | |
| 26-Apr-23 9:22 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-23 | Private Sale (Planned) | 14,400 | $103.48 | $1,490,060.00 | (35%) 41.04K to 26.64K | |
| 08-Feb-23 7:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-23 | Sale (Planned) | 980 | $104.15 | $102,072.00 | (2%) 41.99K to 41.02K | |
| 08-Feb-23 7:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-23 | Sale (Planned) | 14,424 | $102.40 | $1,477,030.00 | (26%) 54.56K to 40.13K | |
| 08-Feb-23 7:40 PM View: | Neurocrine Biosciences Inc. (NBIX) | 06-Feb-23 | Private Sale (Planned) | 1,121 | $105.80 | $118,602.00 | (4%) 28.3K to 27.18K | |
| 02-Feb-23 5:28 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Jan-23 | Private Sale (Planned) | 1,457 | $109.99 | $160,254.00 | (5%) 27.63K to 26.17K | |
| 10-Jun-22 4:11 PM View: | Amicus Therapeutics, Inc. (FOLD) | 09-Jun-22 | Grant | 12,671 | -- | -- | 56% 22.76K to 35.43K | |
| 09-Feb-22 7:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-22 | Sale (Planned) | 980 | $79.52 | $77,930.60 | (4%) 25.61K to 24.63K | |
| 09-Feb-22 7:06 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-22 | Private Sale (Planned) | 2,744 | $80.78 | $221,660.00 | (10%) 26.49K to 23.75K | |
| 12-Jan-22 5:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Jan-22 | Market Sale (Planned) | 2,632 | $74.50 | $196,088.00 | (11%) 23.91K to 21.28K | (3%) |
| 14-Jun-21 7:04 PM View: | Amicus Therapeutics, Inc. (FOLD) | 10-Jun-21 | Grant | 22,759 | -- | -- | 100% 0 to 22.76K | |
| 09-Feb-21 9:21 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Feb-21 | Market Sale (Planned) | 2,363 | $116.78 | $275,944.00 | (11%) 21.06K to 18.69K | < 1% |
| 12-Jan-21 4:17 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-21 | Market Sale (Planned) | 2,632 | $111.06 | $292,297.00 | (14%) 18.48K to 15.85K | (4%) |
| 16-Nov-20 6:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Nov-20 | Market Sale (Planned) | 2,257 | $90.74 | $204,810.00 | (14%) 15.73K to 13.48K | (27%) |
| 07-Aug-20 7:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 05-Aug-20 | Market Sale (Planned) | 2,257 | $118.84 | $268,225.00 | (16%) 13.7K to 11.45K | 3% |
| 25-Jun-20 4:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 23-Jun-20 | Option Exercise | 5,000 | $77.81 | $389,050.00 | 53% 9.42K to 14.42K | 8% |
| 25-Jun-20 4:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 23-Jun-20 | Market Option Sale (Planned) | 5,000 | $130.00 | $650,000.00 | (35%) 14.42K to 9.42K | 11% |
| 28-Apr-20 8:46 PM View: | Neurocrine Biosciences Inc. (NBIX) | 24-Apr-20 | Market Sale (Planned) | 1,934 | $99.47 | $192,376.00 | (17%) 11.35K to 9.42K | (16%) |
| 11-Feb-20 7:23 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Feb-20 | Market Sale (Planned) | 1,623 | $103.31 | $167,675.00 | (18%) 9.07K to 7.45K | (12%) |
| 10-Jan-20 4:10 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-20 | Market Sale (Planned) | 2,632 | $111.11 | $292,445.00 | (31%) 8.62K to 5.99K | (4%) |
| 10-Jan-19 4:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Jan-19 | Market Sale (Planned) | 1,857 | $84.09 | $156,159.00 | (37%) 5.0K to 3.14K | (37%) |